Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001051578-26-000004

Options or other derivatives

  • Director acquired 9,622 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PYOTT DAVID E I · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-18 Grant or award : show line 1 in the form Stock Option (right to buy) +5,893 5,893 D
2026-02-18 Grant or award : show line 2 in the form Restricted Stock Units +3,729 3,729 D
Loading xslF345X05/wk-form4_1771623346.xml…